F Ligand Pharmaceuticals Inc Transaction History
F
- $2.27 Billion
- Q2 2025
A detailed history of F transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, F holds 52,507 shares of LGND stock, worth $8.02 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
52,507
Previous 52,245
0.5%
Holding current value
$8.02 Million
Previous $5.49 Million
8.65%
% of portfolio
0.26%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding LGND
# of Institutions
289Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$319 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$162 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$141 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$114 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.58B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...